Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride
Related Experiment Video
Updated: Oct 21, 2026

A Mouse Model of Intestinal Partial Obstruction
Published on: March 5, 2018
A G Fraser1, J F Arthur, I Hamilton
1Gastroenterology Unit, Auckland Hospital, New Zealand.
Abstract:
A case of chronic intestinal pseudoobstruction secondary to systemic amyloidosis in a patient with multiple myeloma is described. Gastrointestinal symptoms and indices of nutrition improved markedly after commencing treatment with cisapride, which may have been responsible for relatively prolonged survival compared with similar reported cases.
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Pyloric Obstruction
Intestinal Obstruction I: Introduction
Intestinal Obstruction II: Pathophysiology

